Hydromorphone Hydrochloride
- Product NDC
- 71335-0229
- 11-digit product format
- 713350229
- Labeler code
- 71335
- Product ID
- 71335-0229_2064e143-dbf7-4a69-9b42-4763227f22ae
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- hydromorphone hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA076855
- Marketing category
- ANDA
- Marketing start
- 2004-12-23
- Marketing end
- 0000-00-00
- Substance
- HYDROMORPHONE HYDROCHLORIDE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Full Opioid Agonists [MoA], Opioid Agonist [EPC]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-0229-1 | 71335022901 | 30 TABLET in 1 BOTTLE (71335-0229-1) | 30 tablet | 2022-02-09 | 0000-00-00 | No | No | Current |
| 71335-0229-2 | 71335022902 | 60 TABLET in 1 BOTTLE (71335-0229-2) | 60 tablet | 2022-02-09 | 0000-00-00 | No | No | Current |
| 71335-0229-3 | 71335022903 | 90 TABLET in 1 BOTTLE (71335-0229-3) | 90 tablet | 2022-02-09 | 0000-00-00 | No | No | Current |
| 71335-0229-4 | 71335022904 | 120 TABLET in 1 BOTTLE (71335-0229-4) | 120 tablet | 2022-02-09 | 0000-00-00 | No | No | Current |
| 71335-0229-5 | 71335022905 | 20 TABLET in 1 BOTTLE (71335-0229-5) | 20 tablet | 2022-02-09 | 0000-00-00 | No | No | Current |